Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Macular Tissue Integrity Index: a Novel Biomarker for Geographic Atrophy (GA)
Author Affiliations & Notes
  • Karl G Csaky
    Retina Foundation of the Southwest, Dallas, Texas, United States
  • Thomas Saunders
    University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Rachel E Linderman
    University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Rick Voland
    University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Barbara A Blodi
    University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Amitha Domalpally
    University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Footnotes
    Commercial Relationships   Karl Csaky Abbvie, Adverum Biotechnologies, Annexon Biosciences, Cognition Therapeutics, EyeBio, Roche/Genentech, Heidelberg Engineering, Johnson and Johnson, Merck, NGM Biopharmaceuticals, Novartis, Regeneron, TenPoint Therapeutics, Code C (Consultant/Contractor), Annexon Biosciences, NGM Biopharmaceuticals, Johnson and Johnson, Regeneron, Novartis, Genentech/Roche, Code F (Financial Support); Thomas Saunders None; Rachel Linderman None; Rick Voland None; Barbara Blodi None; Amitha Domalpally None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2297. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Karl G Csaky, Thomas Saunders, Rachel E Linderman, Rick Voland, Barbara A Blodi, Amitha Domalpally; Macular Tissue Integrity Index: a Novel Biomarker for Geographic Atrophy (GA). Invest. Ophthalmol. Vis. Sci. 2024;65(7):2297.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The measurement of geographic atrophy (GA) enlargement on fundus autofluorescence (FAF), a standard outcome in clinical trials, often fails to delineate the critical central macular region and its structure-function relationship. We propose a targeted approach in monitoring GA progression within the central macula, highlighting the limited benefit of including GA expansion beyond the 3mm perifoveal zone. This study introduces a biomarker based on tissue integrity in the 1mm and 3mm areas around the fovea, providing a novel approach to understand the functional changes in GA. The present study aims to explore how macular tissue integrity index correlates with best-corrected visual acuity (BCVA) and low-luminance visual acuity (LLVA).

Methods : Manual planimetry was used to delineate non-GA areas on Heidelberg FAF from 20 baseline scans from a GA clinical trial (GSK 341) (figure 1). OCT images were used to confirm GA status within the fovea. The area of non-GA within 1mm and 3mm circles around the center of the fovea was measured as a percentage to define the macular tissue integrity index. Correlation between the index and BCVA and LLVA was analyzed.

Results : The median GA area was 5.23 mm2 (range 0.88-9.64 mm2), with sub foveal GA in 11 (55%) and multifocal GA in 10 (50%). The integrity index ranged from 0-96% in the 1mm zone and 9-95% in the 3mm zone.
In the 1 mm area, the integrity index was significantly correlated with BCVA (r2 = 0.36, p-value = 0.005) but did not correlate with LLVA (r2 = 0.04, p-value = 0.38). Conversely, in the 3mm subfield, we observed opposite correlation patterns, with BCVA (r2 < 0.01, p-value = 0.89) and LLVA (r2 = 0.22, p-value 0.04).

Conclusions : The dichotomy in visual correlations highlights the importance of considering the specific functional roles of different retinal regions when assessing conditions like GA. The contrasting correlations in our study between macular integrity and visual acuity within the 1mm and 3mm foveal zones are likely due to the different distributions of rods and cones. Further research with a larger sample and longitudinal data is needed for validating the macular tissue integrity index's role in GA monitoring.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Figure 1: Representative FAF image graded for area of intact macular tissue within the central 1 and 3 mm.

Figure 1: Representative FAF image graded for area of intact macular tissue within the central 1 and 3 mm.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×